Palifermin improves oral mucositis after high dose chemotherapy and radiotherapy plus stem cell transplantation in people with haematological cancers

被引：2

作者：

Clarkson, J ^{[1
]}

机构：

[1] Univ Dundee, Community Hlth Sci Div, DHSRU, Dundee DD1 4HN, Scotland

来源：

CANCER TREATMENT REVIEWS | 2005年 / 31卷 / 05期

关键词：

D O I：

10.1016/j.ctrv.2005.05.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：413 / 416

页数：4

共 4 条

[1]

CLARKSON JE, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000978

[2] Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: Potential role as mucosal protectant [J].

Meropol, NJ ;

Somer, RA ;

Gutheil, J ;

Pelley, RJ ;

Modiano, MR ;

Rowinsky, EK ;

Rothenberg, ML ;

Redding, SW ;

Serdar, CM ;

Yao, B ;

Heard, R ;

Rosen, LS .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) :1452-1458

[3] Palifermin for oral mucositis after intensive therapy for hematologic cancers [J].

Spielberger, R ;

Stiff, P ;

Bensinger, W ;

Gentile, T ;

Weisdorf, D ;

Kewalramani, T ;

Shea, T ;

Yanovich, S ;

Hansen, K ;

Noga, S ;

McCarty, J ;

LeMaistre, CF ;

Sung, EC ;

Blazar, BR ;

Elhardt, D ;

Chen, MG ;

Emmanouilides, C .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (25) :2590-2598

[4]

WORTHINGTON HV, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001973.PUB2

← 1 →